Clearside Biomedical, Inc.
Biopharmaceutical firm with an FDA-approved microinjector for back-of-the-eye delivery.
CLSD | US
Overview
Corporate Details
- ISIN(s):
- US1850631045
- LEI:
- Country:
- United States of America
- Address:
- 900 NORTH POINT PARKWAY, 30005 ALPHARETTA
- Website:
- https://clearsidebio.com/
- Sector:
- Manufacturing
Description
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye. The company is a leader in suprachoroidal space (SCS) drug administration, having developed the proprietary SCS Microinjector®, which is the first and only FDA-approved technology for accessing this area. This platform enables targeted delivery of therapeutics directly to the site of retinal diseases. Its first commercial product is XIPERE® (triamcinolone acetonide injectable suspension), approved for the treatment of macular edema associated with uveitis. Clearside's clinical pipeline is focused on serious retinal conditions, with its lead candidate, CLS-AX (a tyrosine kinase inhibitor), in late-stage development for wet age-related macular degeneration (wet AMD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Clearside Biomedical, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Clearside Biomedical, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Clearside Biomedical, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
